NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization

Adhoute Xavier; Penaranda Guillaume; Raoul Jean Luc; Bollon Emilie; Pol Bernard; Letreut Yves P.; Perrier Herve; Bayle Olivier; Monnet Olivier; Beaurain Patrick; Muller Cyril; Hardwigsen Jean; Lefolgoc Gaelle; Castellani Paul; Bronowicki Jean P.; Bourliere Marc

首页> 外文期刊>European journal of gastroenterology and hepatology >NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization

【24h】

NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization

机译：通过手术或龙骨化疗栓塞治疗的肝细胞癌患者的NIACE分数

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and aims Hepatocellular carcinoma (HCC) prognostic scores could be useful in addition to the Barcelona Clinic Liver Cancer (BCLC) system to clarify patient prognosis and guide treatment decision. The NIACE (tumor Nodularity, Infiltrative nature of the tumor, serum Alpha-fetoprotein level, Child-Pugh stage, ECOG performance status) score distinguishes different prognosis groups among BCLC A, B, and C HCC patients. Our aims are to evaluate the NIACE score and its additive value in two HCC cohorts treated either by surgery or by chemoembolization, and then according to the BCLC recommendations.

机译：背景和AIMS肝细胞癌（HCC）除了巴塞罗那临床肝癌（BCLC）系统之外可用，以澄清患者预后和指导治疗决策。 NIACE（肿瘤结节性，肿瘤的渗透性，血清α-胎儿蛋白水平，儿童PUGH阶段，ECOG性能状态）得分区分BCLC A，B和C HCC患者的不同预后群体。我们的旨在评估通过手术或化疗栓塞治疗的两种HCC群体中的NIACE评分及其添加剂值，然后根据BCLC建议。

著录项

来源
《European journal of gastroenterology and hepatology》 |2017年第6期|共10页
作者
Adhoute Xavier; Penaranda Guillaume; Raoul Jean Luc; Bollon Emilie; Pol Bernard; Letreut Yves P.; Perrier Herve; Bayle Olivier; Monnet Olivier; Beaurain Patrick; Muller Cyril; Hardwigsen Jean; Lefolgoc Gaelle; Castellani Paul; Bronowicki Jean P.; Bourliere Marc;
展开▼
作者单位

Hop St Joseph Dept Hepatogastroenterol 26 Bd Louvain F-13008 Marseille France;

Inst Paoli Calmette AlphaBio Lab Marseille France;

Inst Paoli Calmette Dept Hepatogastroenterol &

Digest Oncol Marseille France;

CHU Timone Dept Hepatobiliary Surg Marseille France;

Hop St Joseph Dept Hepatobiliary Surg Marseille France;

CHU Timone Dept Hepatobiliary Surg Marseille France;

Hop St Joseph Dept Hepatogastroenterol 26 Bd Louvain F-13008 Marseille France;

Hop St Joseph Dept Radiol Marseille France;

Hop St Joseph Dept Radiol Marseille France;

Hop St Joseph Dept Radiol Marseille France;

Hop St Joseph Dept Radiol Marseille France;

CHU Timone Dept Hepatobiliary Surg Marseille France;

Hop St Joseph Dept Hepatogastroenterol 26 Bd Louvain F-13008 Marseille France;

Hop St Joseph Dept Hepatogastroenterol 26 Bd Louvain F-13008 Marseille France;

CHU Nancy Dept Hepatogastroenterol Vandoeuvre Les Nancy France;

Hop St Joseph Dept Hepatogastroenterol 26 Bd Louvain F-13008 Marseille France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Barcelona Clinic Liver Cancer stage; Cancer of the Liver Italian Program; alpha-fetoprotein; infiltrative tumor; liver cancer; NIACE;

机译：巴塞罗那临床肝癌阶段;肝脏癌症意大利计划;α-胎儿;渗透肿瘤;肝癌;NIACE;

相似文献

外文文献
中文文献
专利

1. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization [J] . Adhoute Xavier, Penaranda Guillaume, Raoul Jean Luc, European journal of gastroenterology and hepatology . 2017,第6期

机译：通过手术或龙骨化疗栓塞治疗的肝细胞癌患者的NIACE分数
2. Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study [J] . Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Gut and Liver . 2020,第4期

机译：治疗切除后常常肝细胞癌因常规肝细胞癌治疗的患者的新风险评分提出：多中心研究
3. ART Score and Predictive Factors of Prognosis in Hepatocellular Carcinoma Patients Treated With Transarterial Chemoembolization [J] . Cardoso Helder, Vilas-Boas Filipe, Marques Margarida, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：经动脉化疗栓塞治疗的肝细胞癌患者的ART得分和预后预测因素
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Validation of the Six-and-Twelve Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients [O] . Apichat Kaewdech, Pimsiri Sripongpun, Natcha Cheewasereechon, 2021

机译：ratrartial Chemoembolization治疗的肝细胞癌患者的六和十二预后评分验证
7. Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma [O] . Zhexuan Wang, Qingling Fan, Mengmeng Wang, 2020

机译：Crond-Pugh评分与白蛋白 - 胆红素等级对泪滴性化疗组合治疗和索拉酮治疗肝细胞癌的比较

NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization

摘要

著录项

相似文献

相关主题

期刊订阅